Helsinki, May 2025 — MVision AI announces that Contour+, its AI-based auto-contouring software for radiation therapy, has received market approval for clinical use in Singapore.…
HELSINKI, Finland – April 2025 — Contour+, MVision AI’s AI-powered auto-contouring software, has received market clearance from the United Arab Emirates Ministry of Health and…
There is a heightened interest in artificial intelligence (AI) applications in the medical world in general, and radiation oncology is no exception. The number of…
MVision Contour+ is an AI-powered auto-segmentation used in radiation therapy planning. Recently, a series of studies published in peer-reviewed journals evaluated its performance and impact…
Radiation Oncology is a medical specialty that, at its core, combines technology and medicine, creating opportunities for spectacular improvements and advances in a relatively short…
Helsinki, Finland – February 2025 – MVision AI announces the introduction of Dose+, a software medical device designed to assist radiation therapy professionals in treatment…
Helsinki, Finland – February 2025 – The Therapeutic Goods Administration (TGA) of Australia has granted market approval for MVision AI’s MR-based segmentation models included in…
World cancer day, celebrated on the 4th of February, was established more than 20 years ago. It represents an initiative of the Union for International…